Caspase	B-protein
-dependent	O
cleavage	O
of	O
the	O
hematopoietic	B-protein
specific	I-protein
adaptor	I-protein
protein	I-protein
Gads	I-protein
alters	O
signalling	O
from	O
the	O
T	B-protein
cell	I-protein
receptor	I-protein
.	O

Gads	B-protein
is	O
a	O
SH2	B-protein
and	I-protein
SH3	I-protein
domain	I-protein
-containing	O
,	O
hematopoietic-specific	B-protein
adaptor	I-protein
protein	I-protein
that	O
functions	O
in	O
signalling	O
from	O
the	O
T	B-protein
cell	I-protein
receptor	I-protein
.	O

Gads	B-protein
acts	O
by	O
linking	O
SLP-76	B-protein
,	O
bound	O
by	O
the	O
carboxy-terminal	B-protein
Gads	I-protein
SH3	I-protein
domain	I-protein
,	O
to	O
tyrosine	B-protein
phosphorylated	I-protein
LAT	I-protein
which	O
contains	O
binding	O
sites	O
for	O
the	O
Gads	B-protein
SH2	I-protein
domain	I-protein
.	O

Gads	B-protein
is	O
distinguished	O
from	O
Grb2	B-protein
and	O
the	O
closely	O
related	O
Grap	B-protein
protein	I-protein
by	O
the	O
presence	O
of	O
a	O
120	B-protein
amino	I-protein
acid	I-protein
unique	I-protein
region	I-protein
between	O
the	O
SH2	B-protein
domain	I-protein
and	O
the	O
carboxy	B-protein
terminal	I-protein
SH3	I-protein
domain	I-protein
.	O

Here	O
we	O
demonstrate	O
that	O
the	O
unique	O
region	O
of	O
Gads	B-protein
contains	O
a	O
capase	B-protein
cleavage	I-protein
site	I-protein
.	O

Induction	O
of	O
apoptosis	O
in	O
lymphocytes	B-cell_type
results	O
in	O
detectable	O
Gads	B-protein
cleavage	O
by	O
60	O
min	O
.	O

Gads	B-protein
cleavage	O
is	O
blocked	O
in	O
vivo	O
by	O
treating	O
cells	O
with	O
a	O
caspase	O
3	O
inhibitor	O
.	O

A	O
putative	B-protein
caspase	I-protein
3	I-protein
cleavage	I-protein
site	I-protein
was	O
identified	O
within	O
the	O
unique	O
region	O
and	O
mutation	O
of	O
this	O
site	O
prevented	O
Gads	B-protein
cleavage	O
in	O
vitro	O
,	O
and	O
in	O
vivo	O
.	O

The	O
Gads	B-protein
cleavage	O
products	O
retained	O
the	O
predicted	O
binding	O
specificity	O
for	O
SLP-76	B-protein
and	O
LAT	B-protein
.	O

Expression	O
of	O
the	O
Gads	B-protein
cleavage	O
products	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
inhibited	O
NFAT	O
activation	O
following	O
TCR	O
cross	O
linking	O
.	O

These	O
findings	O
indicate	O
that	O
cleavage	O
of	O
Gads	B-protein
in	O
vivo	O
could	O
function	O
to	O
alter	O
signalling	O
downstream	O
of	O
the	O
T	B-protein
cell	I-protein
receptor	I-protein
by	O
disrupting	O
cross	O
talk	O
between	O
SLP-76	B-protein
and	O
LAT	B-protein
.	O

Oncogene	NULL
(	NULL
2001	NULL
)	NULL
20	NULL
,	NULL
1203-1211	NULL
Â©	NULL
2001	NULL
Nature	NULL
Publishing	NULL
Group	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/01	NULL
$	NULL
15.00	NULL
www.nature.com/onc	NULL
Caspase-dependent	NULL
cleavage	NULL
of	NULL
the	NULL
hematopoietic	NULL
specific	NULL
adaptor	NULL
protein	NULL
Gads	NULL
alters	NULL
signalling	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
Donna	NULL
M	NULL
Berry	NULL
'	NULL
,	NULL
Sally	NULL
J	NULL
Benn	NULL
'	NULL
,	NULL
Alec	NULL
M	NULL
Cheng	NULL
and	NULL
C	NULL
Jane	NULL
McGlade*	NULL
``	NULL
'The	NULL
Arthur	NULL
and	NULL
Sonia	NULL
Labatt	NULL
Brain	NULL
Tumour	NULL
Research	NULL
Centre	NULL
,	NULL
The	NULL
Hospital	NULL
for	NULL
Sick	NULL
Children	NULL
,	NULL
Toronto	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
.	NULL

MSG	NULL
1X8	NULL
;	NULL
Division	NULL
of	NULL
Rheumatology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
MO	NULL
,	NULL
USA	NULL
Gads	NULL
is	NULL
a	NULL
SH2	NULL
and	NULL
SH3	NULL
domain-containing	NULL
,	NULL
hemato-poietic-specific	NULL
adaptor	NULL
protein	NULL
that	NULL
functions	NULL
in	NULL
signalling	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
.	NULL

Gads	NULL
acts	NULL
by	NULL
linking	NULL
SLP-76	NULL
,	NULL
bound	NULL
by	NULL
the	NULL
carboxy-terminal	NULL
Gads	NULL
SH3	NULL
domain	NULL
,	NULL
to	NULL
tyrosine	NULL
phosphorylated	NULL
LAT	NULL
which	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
Gads	NULL
SH2	NULL
domain	NULL
.	NULL

Gads	NULL
is	NULL
distinguished	NULL
from	NULL
Grb2	NULL
and	NULL
the	NULL
closely	NULL
related	NULL
Grap	NULL
protein	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
120	NULL
amino	NULL
acid	NULL
unique	NULL
region	NULL
between	NULL
the	NULL
SH2	NULL
domain	NULL
and	NULL
the	NULL
carboxy	NULL
terminal	NULL
SH3	NULL
domain	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
unique	NULL
region	NULL
of	NULL
Gads	NULL
contains	NULL
a	NULL
capase	NULL
cleavage	NULL
site	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
lymphocytes	NULL
results	NULL
in	NULL
detectable	NULL
Gads	NULL
cleavage	NULL
by	NULL
60	NULL
min	NULL
.	NULL

Gads	NULL
cleavage	NULL
is	NULL
blocked	NULL
in	NULL
vivo	NULL
by	NULL
treating	NULL
cells	NULL
with	NULL
a	NULL
caspase	NULL
3	NULL
inhibitor	NULL
.	NULL

A	NULL
putative	NULL
caspase	NULL
3	NULL
cleavage	NULL
site	NULL
was	NULL
identified	NULL
within	NULL
the	NULL
unique	NULL
region	NULL
and	NULL
mutation	NULL
of	NULL
this	NULL
site	NULL
prevented	NULL
Gads	NULL
cleavage	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
Gads	NULL
cleavage	NULL
products	NULL
retained	NULL
the	NULL
predicted	NULL
binding	NULL
specificity	NULL
for	NULL
SLP-76	NULL
and	NULL
LAT	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Gads	NULL
cleavage	NULL
products	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
inhibited	NULL
NFAT	NULL
activation	NULL
following	NULL
TCR	NULL
cross	NULL
linking	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
cleavage	NULL
of	NULL
Gads	NULL
in	NULL
vivo	NULL
could	NULL
function	NULL
to	NULL
alter	NULL
signalling	NULL
downstream	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
by	NULL
disrupting	NULL
cross	NULL
talk	NULL
between	NULL
SLP-76	NULL
and	NULL
LAT	NULL
.	NULL

Oncogene	NULL
(	NULL
2001	NULL
)	NULL
20	NULL
,	NULL
1203-1211	NULL
.	NULL

Keywords	NULL
:	NULL
Gads	NULL
;	NULL
caspase	NULL
;	NULL
T	NULL
cell	NULL
receptor	NULL
;	NULL
SH2	NULL
domain	NULL
;	NULL
SH3	NULL
domain	NULL
Introduction	NULL
Apoptosis	NULL
is	NULL
important	NULL
in	NULL
the	NULL
normal	NULL
development	NULL
and	NULL
homeostasis	NULL
of	NULL
multicellular	NULL
organisms	NULL
.	NULL

The	NULL
process	NULL
of	NULL
apoptosis	NULL
is	NULL
tightly	NULL
regulated	NULL
by	NULL
a	NULL
number	NULL
of	NULL
biochemical	NULL
signalling	NULL
pathways	NULL
.	NULL

The	NULL
Caenorhabditis	NULL
elegans	NULL
cell	NULL
death	NULL
gene	NULL
ced-3	NULL
and	NULL
its	NULL
mammalian	NULL
homologue	NULL
interleukin-1B-converting	NULL
enzyme	NULL
(	NULL
ICE/	NULL
Caspase-1	NULL
)	NULL
are	NULL
prototypical	NULL
members	NULL
of	NULL
a	NULL
family	NULL
of	NULL
cysteine-dependent	NULL
aspartate	NULL
directed	NULL
proteases	NULL
(	NULL
cas-pases	NULL
)	NULL
(	NULL
Nicholson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Yuan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

This	NULL
family	NULL
of	NULL
proteases	NULL
has	NULL
13	NULL
known	NULL
members	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
mediating	NULL
*Correspondence	NULL
:	NULL
CJ	NULL
McGlade	NULL
,	NULL
The	NULL
Hospital	NULL
for	NULL
Sick	NULL
Children	NULL
,	NULL
555	NULL
University	NULL
Avenue	NULL
,	NULL
Toronto	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
MSG	NULL
1X8	NULL
Received	NULL
10	NULL
October	NULL
2000	NULL
;	NULL
revised	NULL
15	NULL
December	NULL
2000	NULL
;	NULL
accepted	NULL
3	NULL
January	NULL
2001	NULL
apoptotic	NULL
cell	NULL
death	NULL
(	NULL
Earnshaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Fadeel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Villa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
non-apoptotic	NULL
cells	NULL
,	NULL
caspases	NULL
exist	NULL
as	NULL
zymogens	NULL
,	NULL
which	NULL
become	NULL
active	NULL
through	NULL
either	NULL
self-proteolysis	NULL
or	NULL
cleavage	NULL
by	NULL
other	NULL
caspase	NULL
family	NULL
members	NULL
.	NULL

Current	NULL
data	NULL
suggest	NULL
that	NULL
cell	NULL
death	NULL
signals	NULL
result	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
caspase-8	NULL
,	NULL
9	NULL
or	NULL
2	NULL
which	NULL
then	NULL
mediate	NULL
cleavage	NULL
and	NULL
activation	NULL
of	NULL
downstream	NULL
effector	NULL
caspases	NULL
(	NULL
3	NULL
,	NULL
6	NULL
and	NULL
7	NULL
)	NULL
(	NULL
Earnshaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Effector	NULL
caspases	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
cleavage	NULL
of	NULL
specific	NULL
target	NULL
proteins	NULL
,	NULL
thereby	NULL
mediating	NULL
the	NULL
events	NULL
associated	NULL
with	NULL
cell	NULL
death	NULL
.	NULL

To	NULL
date	NULL
,	NULL
a	NULL
number	NULL
of	NULL
effector	NULL
caspase	NULL
targets	NULL
have	NULL
been	NULL
identified	NULL
including	NULL
structural	NULL
components	NULL
of	NULL
the	NULL
cytoskeleton	NULL
and	NULL
nucleus	NULL
,	NULL
DNA	NULL
repair	NULL
enzymes	NULL
and	NULL
signalling	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
cycle	NULL
and	NULL
survival	NULL
(	NULL
Earnshaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
-mediated	NULL
apoptosis	NULL
,	NULL
or	NULL
activation-induced	NULL
cell	NULL
death	NULL
(	NULL
AICD	NULL
)	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
negative	NULL
selection	NULL
of	NULL
immature	NULL
T	NULL
cells	NULL
within	NULL
the	NULL
thymus	NULL
and	NULL
maintaining	NULL
the	NULL
function	NULL
of	NULL
mature	NULL
peripheral	NULL
T	NULL
cells	NULL
(	NULL
Brunner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
Ju	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
leads	NULL
to	NULL
increased	NULL
transcription	NULL
of	NULL
both	NULL
the	NULL
Fas	NULL
receptor	NULL
(	NULL
CD95	NULL
)	NULL
and	NULL
its	NULL
extracellular	NULL
ligand	NULL
FasL	NULL
(	NULL
Russell	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
Fas	NULL
and	NULL
FasL	NULL
initiates	NULL
the	NULL
cell	NULL
death	NULL
signalling	NULL
cascade	NULL
which	NULL
mediates	NULL
AICD	NULL
by	NULL
promoting	NULL
receptor	NULL
aggregation	NULL
and	NULL
the	NULL
recruitment	NULL
of	NULL
the	NULL
adaptor	NULL
protein	NULL
FADD	NULL
and	NULL
its	NULL
associated	NULL
caspase-8	NULL
(	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Muzio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Yang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Increased	NULL
concentration	NULL
of	NULL
caspase-8	NULL
in	NULL
proximity	NULL
to	NULL
the	NULL
receptor	NULL
leads	NULL
to	NULL
auto-activation	NULL
of	NULL
caspase-8	NULL
and	NULL
subsequent	NULL
activation	NULL
of	NULL
downstream	NULL
effector	NULL
caspases	NULL
and	NULL
cleavage	NULL
of	NULL
cellular	NULL
proteins	NULL
responsible	NULL
for	NULL
controlled	NULL
cellular	NULL
destruction	NULL
(	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Muzio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Initiation	NULL
of	NULL
signalling	NULL
events	NULL
from	NULL
the	NULL
TCR	NULL
involves	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
residues	NULL
in	NULL
the	NULL
intracellular	NULL
domains	NULL
of	NULL
the	NULL
receptor	NULL
CD3	NULL
complex	NULL
by	NULL
Src-family	NULL
kinases	NULL
including	NULL
Lock	NULL
and	NULL
Fyn	NULL
(	NULL
Chan	NULL
and	NULL
Shaw	NULL
,	NULL
1996	NULL
;	NULL
Wange	NULL
and	NULL
Samelson	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
these	NULL
residues	NULL
creates	NULL
a	NULL
SH2	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
ZAP-70	NULL
,	NULL
which	NULL
is	NULL
subsequently	NULL
phosphorylated	NULL
and	NULL
activated	NULL
by	NULL
Lock	NULL
(	NULL
Chan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Wange	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
ZAP-70	NULL
initiates	NULL
multiple	NULL
signalling	NULL
pathways	NULL
through	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
downstream	NULL
substrates	NULL
,	NULL
including	NULL
enzymes	NULL
such	NULL
as	NULL
Phospholipase	NULL
Cyl	NULL
(	NULL
Weiss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
Vav	NULL
Caspase-dependent	NULL
cleavage	NULL
of	NULL
Gads	NULL
DM	NULL
Berry	NULL
et	NULL
al	NULL
1204	NULL
(	NULL
Bustelo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
hematopoietic	NULL
specific	NULL
adaptor	NULL
and	NULL
docking	NULL
proteins	NULL
including	NULL
the	NULL
linker	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
LAT	NULL
)	NULL
(	NULL
Buday	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Nel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Weber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998b	NULL
)	NULL
and	NULL
SH2	NULL
domain-containing	NULL
leukocyte	NULL
protein	NULL
of	NULL
76	NULL
kDa	NULL
(	NULL
SLP-76	NULL
)	NULL
(	NULL
Jackman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
SLP-76	NULL
and	NULL
LAT	NULL
adaptor	NULL
proteins	NULL
are	NULL
fundamental	NULL
in	NULL
coordinating	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
Ras-Erk	NULL
and	NULL
Ca**+-mobilization	NULL
pathways	NULL
and	NULL
both	NULL
are	NULL
essential	NULL
for	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
activation	NULL
(	NULL
Finco	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Jackman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Yablonski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998b	NULL
,	NULL
1999	NULL
)	NULL
.	NULL

Gads	NULL
is	NULL
a	NULL
hematopoietic	NULL
adaptor	NULL
protein	NULL
with	NULL
amino	NULL
and	NULL
carboxy	NULL
terminal	NULL
SH3	NULL
domains	NULL
flanking	NULL
a	NULL
central	NULL
SH2	NULL
domain	NULL
(	NULL
Asada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Law	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Liu	NULL
and	NULL
McGlade	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

Gads	NULL
is	NULL
most	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
adaptors	NULL
Grb2	NULL
and	NULL
Grap	NULL
but	NULL
contains	NULL
a	NULL
unique	NULL
region	NULL
rich	NULL
in	NULL
glutamine	NULL
and	NULL
proline	NULL
residues	NULL
for	NULL
which	NULL
a	NULL
function	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
.	NULL

Gads	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
signalling	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
by	NULL
linking	NULL
the	NULL
adaptor	NULL
proteins	NULL
SLP-76	NULL
and	NULL
LAT	NULL
upon	NULL
TCR	NULL
engagement	NULL
.	NULL

SLP-76	NULL
is	NULL
constitutively	NULL
associated	NULL
with	NULL
Gads	NULL
through	NULL
the	NULL
carboxy-terminal	NULL
SH3	NULL
domain	NULL
of	NULL
Gads	NULL
,	NULL
while	NULL
LAT	NULL
is	NULL
inducibly	NULL
associated	NULL
via	NULL
the	NULL
SH2	NULL
domain	NULL
(	NULL
Liu	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
Gads	NULL
can	NULL
synergize	NULL
with	NULL
SLP-76	NULL
to	NULL
augment	NULL
NFAT	NULL
and	NULL
IL-2	NULL
activation	NULL
,	NULL
while	NULL
a	NULL
SH2-inactivated	NULL
form	NULL
of	NULL
Gads	NULL
inhibits	NULL
this	NULL
activation	NULL
(	NULL
Asada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Law	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
cell	NULL
death	NULL
triggered	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
Fas	NULL
receptor	NULL
results	NULL
in	NULL
the	NULL
cleavage	NULL
of	NULL
Gads	NULL
.	NULL

We	NULL
show	NULL
that	NULL
this	NULL
cleavage	NULL
is	NULL
mediated	NULL
by	NULL
caspase	NULL
3	NULL
and	NULL
that	NULL
the	NULL
conserved	NULL
cleavage	NULL
site	NULL
lies	NULL
within	NULL
the	NULL
unique	NULL
linker	NULL
region	NULL
of	NULL
Gads	NULL
which	NULL
distinguishes	NULL
it	NULL
from	NULL
Grb2	NULL
and	NULL
Grap	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
found	NULL
SLP-76	NULL
and	NULL
LAT	NULL
are	NULL
also	NULL
cleaved	NULL
with	NULL
similar	NULL
kinetics	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
important	NULL
role	NULL
of	NULL
the	NULL
Gads-SLP-76-LAT	NULL
complex	NULL
in	NULL
TCR	NULL
signalling	NULL
,	NULL
we	NULL
also	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
Gads	NULL
caspase	NULL
cleavage	NULL
products	NULL
on	NULL
distal	NULL
signalling	NULL
events	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
either	NULL
the	NULL
C-terminal	NULL
or	NULL
N-terminal	NULL
cleavage	NULL
products	NULL
inhibited	NULL
NFAT	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
caspase-mediated	NULL
cleavage	NULL
of	NULL
Gads	NULL
alters	NULL
signalling	NULL
from	NULL
the	NULL
activated	NULL
TCR	NULL
.	NULL

Results	NULL
FasL	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
induces	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
Gads	NULL
During	NULL
the	NULL
course	NULL
of	NULL
our	NULL
analysis	NULL
of	NULL
Gads	NULL
protein	NULL
expression	NULL
in	NULL
primary	NULL
lymphocytes	NULL
,	NULL
a	NULL
faster	NULL
migrating	NULL
protein	NULL
which	NULL
was	NULL
immunoreactive	NULL
with	NULL
anti-Gads	NULL
antisera	NULL
was	NULL
observed	NULL
(	NULL
Figure	NULL
la	NULL
)	NULL
.	NULL

We	NULL
considered	NULL
that	NULL
this	NULL
Gads	NULL
reactive	NULL
band	NULL
might	NULL
be	NULL
generated	NULL
by	NULL
proteolytic	NULL
cleavage	NULL
as	NULL
a	NULL
result	NULL
of	NULL
caspase	NULL
activation	NULL
,	NULL
a	NULL
consequence	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
which	NULL
is	NULL
triggered	NULL
when	NULL
primary	NULL
cells	NULL
are	NULL
placed	NULL
in	NULL
culture	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
similar	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
Gads	NULL
occurred	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
Fas	NULL
ligand	NULL
(	NULL
FasL	NULL
)	NULL
,	NULL
which	NULL
activates	NULL
the	NULL
cell	NULL
death	NULL
Oncogene	NULL
receptor	NULL
Fas	NULL
and	NULL
initiates	NULL
a	NULL
caspase	NULL
cascade	NULL
.	NULL

Following	NULL
treatment	NULL
with	NULL
FasL	NULL
for	NULL
up	NULL
to	NULL
150	NULL
min	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
protein	NULL
lysates	NULL
analysed	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
Figure	NULL
1b	NULL
)	NULL
.	NULL

We	NULL
found	NULL
the	NULL
appearance	NULL
of	NULL
anti-Gads	NULL
reactive	NULL
cleavage	NULL
product	NULL
by	NULL
90	NULL
min	NULL
,	NULL
at	NULL
the	NULL
same	NULL
time	NULL
that	NULL
cleavage	NULL
of	NULL
PARP	NULL
,	NULL
a	NULL
known	NULL
substrate	NULL
of	NULL
caspase	NULL
3	NULL
is	NULL
detected	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
when	NULL
the	NULL
Gads	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
for	NULL
the	NULL
known	NULL
Gads-associated	NULL
protein	NULL
SLP-76	NULL
,	NULL
it	NULL
was	NULL
discovered	NULL
that	NULL
it	NULL
too	NULL
undergoes	NULL
proteolytic	NULL
cleavage	NULL
after	NULL
Fas	NULL
receptor	NULL
activation	NULL
.	NULL

Microscopic	NULL
examination	NULL
of	NULL
the	NULL
cells	NULL
confirmed	NULL
that	NULL
FasL	NULL
stimulation	NULL
resulted	NULL
in	NULL
approximately	NULL
60	NULL
%	NULL
of	NULL
cells	NULL
undergoing	NULL
apoptotic	NULL
cell	NULL
death	NULL
after	NULL
90	NULL
min	NULL
.	NULL

Other	NULL
agents	NULL
known	NULL
to	NULL
trigger	NULL
apoptotic	NULL
cell	NULL
death	NULL
,	NULL
such	NULL
as	NULL
etoposide	NULL
and	NULL
staurosporine	NULL
also	NULL
resulted	NULL
in	NULL
cleavage	NULL
of	NULL
Gads	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
lc	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
K562	NULL
leukaemia	NULL
cell	NULL
line	NULL
with	NULL
etoposide	NULL
did	NULL
not	NULL
result	NULL
in	NULL
any	NULL
observable	NULL
cell	NULL
death	NULL
and	NULL
also	NULL
did	NULL
not	NULL
cause	NULL
cleavage	NULL
of	NULL
Gads	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
initiation	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
T	NULL
cells	NULL
triggers	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
Gads	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
Gads	NULL
resides	NULL
within	NULL
specific	NULL
protein	NULL
complexes	NULL
,	NULL
some	NULL
constitutive	NULL
and	NULL
some	NULL
induced	NULL
following	NULL
TCR	NULL
stimulation	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
FasL	NULL
stimulation	NULL
also	NULL
resulted	NULL
in	NULL
cleavage	NULL
of	NULL
other	NULL
components	NULL
of	NULL
these	NULL
complexes	NULL
.	NULL

Following	NULL
FasL	NULL
stimulation	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
whole	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
indicated	NULL
anti-sera	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Cleavage	NULL
products	NULL
were	NULL
detected	NULL
when	NULL
protein	NULL
lysates	NULL
were	NULL
blotted	NULL
for	NULL
the	NULL
known	NULL
Gads	NULL
associated	NULL
protein	NULL
LAT	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
the	NULL
SLP-76	NULL
associated	NULL
protein	NULL
SLAP-130	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Other	NULL
LAT	NULL
associated	NULL
molecules	NULL
including	NULL
Grb2	NULL
,	NULL
SOS	NULL
and	NULL
PLCy	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
cleaved	NULL
following	NULL
FasL	NULL
stimula-tion	NULL
,	NULL
suggesting	NULL
that	NULL
Gads	NULL
complexes	NULL
are	NULL
specifically	NULL
cleaved	NULL
.	NULL

The	NULL
linker	NULL
region	NULL
of	NULL
Gads	NULL
contains	NULL
a	NULL
caspase	NULL
3	NULL
cleavage	NULL
site	NULL
Inspection	NULL
of	NULL
the	NULL
Gads	NULL
amino	NULL
acid	NULL
sequence	NULL
revealed	NULL
that	NULL
the	NULL
unique	NULL
linker	NULL
region	NULL
between	NULL
the	NULL
SH2	NULL
domain	NULL
and	NULL
the	NULL
carboxy	NULL
terminal	NULL
SH3	NULL
domain	NULL
contains	NULL
a	NULL
potential	NULL
caspase	NULL
cleavage	NULL
site	NULL
(	NULL
Figure	NULL
3a	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
throughout	NULL
the	NULL
linker	NULL
region	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
Gads	NULL
is	NULL
not	NULL
absolutely	NULL
conserved	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
putative	NULL
cleavage	NULL
site	NULL
at	NULL
amino	NULL
acids	NULL
232-235	NULL
is	NULL
identical	NULL
in	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
sequences	NULL
(	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

Cleavage	NULL
of	NULL
the	NULL
Gads	NULL
protein	NULL
at	NULL
this	NULL
site	NULL
would	NULL
yield	NULL
an	NULL
anti-Gads	NULL
immunoreactive	NULL
protein	NULL
with	NULL
a	NULL
predicted	NULL
molecular	NULL
weight	NULL
of	NULL
approximately	NULL
24	NULL
kDa	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
size	NULL
of	NULL
the	NULL
cleavage	NULL
product	NULL
observed	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

Since	NULL
the	NULL
sequence	NULL
in	NULL
Gads	NULL
most	NULL
closely	NULL
matched	NULL
the	NULL
consensus	NULL
cleavage	NULL
site	NULL
for	NULL
the	NULL
caspase	NULL
3	NULL
family	NULL
of	NULL
proteases	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
specific	NULL
caspase	NULL
inhibitors	NULL
would	NULL
block	NULL
Gads	NULL
cleavage	NULL
following	NULL
FasL	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Figure	NULL
3b	NULL
shows	NULL
that	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
both	NULL
a	NULL
pan-caspase	NULL
inhibitor	NULL
as	NULL
well	NULL
as	NULL
a	NULL
caspase	NULL
3	NULL
specific	NULL
inhibitor	NULL
prevented	NULL
Gads	NULL
cleavage	NULL
.	NULL

An	NULL
inhibitor	NULL
of	NULL
Caspase	NULL
1	NULL
(	NULL
ICE	NULL
)	NULL
family	NULL
members	NULL
did	NULL
0	NULL
24	NULL
hr	NULL
MW	NULL
:	NULL
55	NULL
-	NULL
w-~	NULL
Â«	NULL
38	NULL
-	NULL
#	NULL
ipbam	NULL
Â»	NULL
<	NULL
Gads	NULL
33.5	NULL
-	NULL
``	NULL
f	NULL
E3	NULL
e	NULL
0	NULL
O	NULL
G	NULL
GQ	NULL
Ko	NULL
la	NULL
8	NULL
la	NULL
O	NULL
-	NULL
z	NULL
O	NULL
Q	NULL
.	NULL

-	NULL
3	NULL
Q.	NULL
b	NULL
28	NULL
Â§	NULL
E	NULL
28	NULL
-	NULL
@	NULL
2	NULL
LL	NULL
(	NULL
A	NULL
-2	NULL
-	NULL
LLJ	NULL
p	NULL
Â«	NULL
emcee	NULL
cue	NULL
cate	NULL
Jurkat	NULL
K562	NULL
Caspase-dependent	NULL
cleavage	NULL
of	NULL
Gads	NULL
DM	NULL
Berry	NULL
et	NULL
al	NULL
1205	NULL
b	NULL
Fas	NULL
L	NULL
:	NULL
O0	NULL
15	NULL
30	NULL
60	NULL
90	NULL
120	NULL
150	NULL
minutes	NULL
mw	NULL
36	NULL
_-	NULL
<	NULL
Gacds	NULL
26-	NULL
--	NULL
â	NULL
70_-	NULL
wo	NULL
cues	NULL
ames	NULL
aam	NULL
vas	NULL
~*	NULL
4	NULL
SLP-7G	NULL
90-	NULL
fg	NULL
.	NULL

-*	NULL
Â«	NULL
Figure	NULL
1	NULL
Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
Gads	NULL
and	NULL
SLP-76	NULL
(	NULL
a	NULL
)	NULL
Primary	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
and	NULL
cultured	NULL
for	NULL
24	NULL
h.	NULL
Gads	NULL
was	NULL
immunoprecipitated	NULL
and	NULL
Western	NULL
blotted	NULL
with	NULL
anti-Gads	NULL
anti-sera	NULL
.	NULL

The	NULL
immunoreactive	NULL
bands	NULL
corresponding	NULL
to	NULL
Gads	NULL
and	NULL
a	NULL
26	NULL
kDa	NULL
product	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Gads	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
lysates	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
FasL	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

The	NULL
Gads	NULL
immunoprecipitates	NULL
were	NULL
blotted	NULL
with	NULL
anti-Gads	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
immunoreactive	NULL
full	NULL
length	NULL
Gads	NULL
and	NULL
the	NULL
putative	NULL
cleavage	NULL
product	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
Gads	NULL
associated	NULL
molecule	NULL
SLP-76	NULL
was	NULL
also	NULL
cleaved	NULL
during	NULL
apoptosis	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
stripped	NULL
and	NULL
blotted	NULL
with	NULL
SLP-76	NULL
anti-sera	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
full	NULL
length	NULL
SLP-76	NULL
and	NULL
a	NULL
faster	NULL
migrating	NULL
immunoreactive	NULL
species	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
from	NULL
the	NULL
same	NULL
FasL	NULL
treated	NULL
samples	NULL
were	NULL
blotted	NULL
with	NULL
anti-PARP	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
full	NULL
length	NULL
and	NULL
cleavage	NULL
product	NULL
of	NULL
PARP	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Jurkat	NULL
T	NULL
or	NULL
K562	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
etoposide	NULL
or	NULL
staurosporine	NULL
to	NULL
induce	NULL
cell	NULL
death	NULL
.	NULL

Gads	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
cell	NULL
lysates	NULL
and	NULL
membranes	NULL
were	NULL
blotted	NULL
with	NULL
anti-Gads	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
immunoreactive	NULL
full	NULL
length	NULL
Gads	NULL
and	NULL
the	NULL
putative	NULL
cleavage	NULL
product	NULL
not	NULL
protect	NULL
Gads	NULL
from	NULL
cleavage	NULL
,	NULL
suggesting	NULL
that	NULL
Gads	NULL
is	NULL
likely	NULL
a	NULL
caspase	NULL
3	NULL
target	NULL
.	NULL

In	NULL
order	NULL
to	NULL
confirm	NULL
that	NULL
Gads	NULL
was	NULL
a	NULL
caspase	NULL
3	NULL
substrate	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
cleavage	NULL
site	NULL
,	NULL
an	NULL
in	NULL
vitro	NULL
cleavage	NULL
assay	NULL
was	NULL
performed	NULL
using	NULL
recombinant	NULL
caspases	NULL
and	NULL
in	NULL
vitro	NULL
translated	NULL
*S-methionine	NULL
labeled	NULL
Gads	NULL
protein	NULL
(	NULL
Figure	NULL
4a	NULL
)	NULL
.	NULL

A	NULL
mutant	NULL
form	NULL
of	NULL
Gads	NULL
in	NULL
which	NULL
aspartic	NULL
acid	NULL
235	NULL
,	NULL
within	NULL
the	NULL
putative	NULL
cleavage	NULL
site	NULL
,	NULL
was	NULL
changed	NULL
to	NULL
alanine	NULL
,	NULL
was	NULL
also	NULL
used	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
assay	NULL
.	NULL

Caspase	NULL
3	NULL
efficiently	NULL
cleaved	NULL
wild	NULL
type	NULL
Gads	NULL
but	NULL
not	NULL
Gads	NULL
D235A	NULL
confirming	NULL
that	NULL
this	NULL
site	NULL
is	NULL
a	NULL
caspase	NULL
3	NULL
cleavage	NULL
site	NULL
.	NULL

Caspase	NULL
7	NULL
appeared	NULL
to	NULL
cleave	NULL
Gads	NULL
very	NULL
inefficiently	NULL
,	NULL
suggesting	NULL
that	NULL
Gads	NULL
is	NULL
a	NULL
specific	NULL
target	NULL
of	NULL
caspase	NULL
3	NULL
in	NULL
vitro	NULL
.	NULL

When	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
only	NULL
the	NULL
wild-type	NULL
form	NULL
of	NULL
Gads	NULL
but	NULL
not	NULL
the	NULL
D235A	NULL
mutant	NULL
was	NULL
cleaved	NULL
following	NULL
FasL	NULL
treatment	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
DIND**	NULL
sequence	NULL
within	NULL
the	NULL
Gads	NULL
linker	NULL
region	NULL
is	NULL
also	NULL
required	NULL
for	NULL
caspase	NULL
cleavage	NULL
of	NULL
Gads	NULL
in	NULL
vivo	NULL
(	NULL
Figure	NULL
4b	NULL
)	NULL
.	NULL

Binding	NULL
specificity	NULL
of	NULL
the	NULL
Gads	NULL
cleavage	NULL
products	NULL
Gads	NULL
functions	NULL
as	NULL
an	NULL
adaptor	NULL
protein	NULL
that	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
assembling	NULL
a	NULL
complex	NULL
containing	NULL
LAT	NULL
and	NULL
SLP-76	NULL
,	NULL
via	NULL
its	NULL
SH2	NULL
and	NULL
carboxy-terminal	NULL
SH3	NULL
domain	NULL
respectively	NULL
,	NULL
that	NULL
is	NULL
important	NULL
for	NULL
signalling	NULL
downstream	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Cleavage	NULL
of	NULL
Gads	NULL
at	NULL
D235	NULL
would	NULL
result	NULL
in	NULL
the	NULL
release	NULL
of	NULL
the	NULL
carboxy	NULL
terminal	NULL
SH3	NULL
domain	NULL
of	NULL
Gads	NULL
from	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
protein	NULL
consisting	NULL
of	NULL
the	NULL
amino	NULL
terminal	NULL
SH3	NULL
domain	NULL
and	NULL
the	NULL
central	NULL
SH2	NULL
domain	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
how	NULL
such	NULL
a	NULL
cleavage	NULL
event	NULL
could	NULL
alter	NULL
the	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
Gads	NULL
SH2	NULL
and	NULL
SH3	NULL
domains	NULL
and	NULL
their	NULL
interaction	NULL
with	NULL
targets	NULL
following	NULL
T	NULL
cell	NULL
receptor	NULL
activation	NULL
.	NULL

Epitope	NULL
tagged	NULL
Oncogene	NULL
a	NULL
Caspase-dependent	NULL
cleavage	NULL
of	NULL
Gads	NULL
DM	NULL
Berry	NULL
et	NULL
al	NULL
1206	NULL
Gads	NULL
proteins	NULL
representative	NULL
of	NULL
the	NULL
two	NULL
cleavage	NULL
products	NULL
were	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Following	NULL
Fas	NULL
L	NULL
:	NULL
0	NULL
15	NULL
30	NULL
60	NULL
90	NULL
120	NULL
150	NULL
minutes	NULL
<	NULL
!	NULL

tmc	NULL
dock	NULL
que	NULL
|	NULL
4M	NULL
--	NULL
Â«	NULL
-o	NULL
m	NULL
Â»	NULL
qm	NULL
can	NULL
ws	NULL
us	NULL
as	NULL
4508	NULL
_	NULL
udu	NULL
.	NULL

T	NULL
Figure	NULL
2	NULL
Cleavage	NULL
of	NULL
Gads	NULL
associated	NULL
molecules	NULL
following	NULL
FasL	NULL
stimulation	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
FasL	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Protein	NULL
lysates	NULL
of	NULL
treated	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blotted	NULL
with	NULL
the	NULL
indicated	NULL
anti-sera	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
the	NULL
full	NULL
length	NULL
protein	NULL
and	NULL
putative	NULL
cleavage	NULL
product	NULL
in	NULL
each	NULL
panel	NULL
TCR	NULL
activation	NULL
the	NULL
Gads	NULL
construct	NULL
representing	NULL
the	NULL
amino	NULL
terminal	NULL
cleavage	NULL
product	NULL
(	NULL
CL-N	NULL
)	NULL
was	NULL
found	NULL
to	NULL
associate	NULL
with	NULL
LAT	NULL
while	NULL
the	NULL
carboxy	NULL
terminal	NULL
product	NULL
(	NULL
CL-C	NULL
)	NULL
did	NULL
not	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
carboxy	NULL
terminal	NULL
cleavage	NULL
product	NULL
efficiently	NULL
associated	NULL
with	NULL
SLP-76	NULL
independent	NULL
of	NULL
TCR	NULL
activation	NULL
.	NULL

Furthermore	NULL
,	NULL
examination	NULL
of	NULL
the	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
bound	NULL
to	NULL
each	NULL
cleavage	NULL
product	NULL
following	NULL
TCR	NULL
activation	NULL
did	NULL
not	NULL
reveal	NULL
the	NULL
presence	NULL
of	NULL
any	NULL
new	NULL
co-immunoprecipitating	NULL
proteins	NULL
,	NULL
suggesting	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
Gads	NULL
SH2	NULL
and	NULL
SH3	NULL
domains	NULL
is	NULL
retained	NULL
even	NULL
in	NULL
the	NULL
cleaved	NULL
form	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
cleavage	NULL
of	NULL
Gads	NULL
could	NULL
uncouple	NULL
SLP-76	NULL
and	NULL
LAT	NULL
downstream	NULL
of	NULL
the	NULL
TCR	NULL
.	NULL

Gads	NULL
cleavage	NULL
products	NULL
alter	NULL
TCR	NULL
signalling	NULL
To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
Gads	NULL
cleavage	NULL
on	NULL
downstream	NULL
signalling	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
,	NULL
we	NULL
measured	NULL
IL-2	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
following	NULL
TCR	NULL
cross	NULL
linking	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
transiently	NULL
expressed	NULL
Gads	NULL
cleavage	NULL
products	NULL
.	NULL

The	NULL
transient	NULL
over	NULL
expression	NULL
of	NULL
SLP-76	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
enhance	NULL
transcription	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
NFAT	NULL
-binding	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
ligation	NULL
(	NULL
Motto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Co-expression	NULL
of	NULL
either	NULL
of	NULL
the	NULL
Gads	NULL
caspase	NULL
cleavage	NULL
products	NULL
with	NULL
SLP-76	NULL
inhibited	NULL
this	NULL
enhanced	NULL
anti-CD3	NULL
dependent	NULL
activation	NULL
of	NULL
NFAT	NULL
(	NULL
Figure	NULL
6a	NULL
)	NULL
.	NULL

No	NULL
difference	NULL
in	NULL
the	NULL
maximum	NULL
luciferase	NULL
units	NULL
induced	NULL
by	NULL
ionomycin	NULL
and	NULL
PMA	NULL
was	NULL
observed	NULL
between	NULL
transfectants	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
Gads	NULL
cleavage	NULL
products	NULL
is	NULL
proximal	NULL
to	NULL
the	NULL
TCR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Previously	NULL
EDI	NULL
[	NULL
49235	NULL
I	NULL
SH3	NULL
I-321aa	NULL
Cleavage	NULL
site	NULL
-	NULL
B86aa	NULL
--	NULL
INHIBITORS	NULL
+	NULL
DEVD	NULL
+	NULL
VAD	NULL
Fas	NULL
L	NULL
:	NULL
-	NULL
+	NULL
MW	NULL
+	NULL
YVAD	NULL
38	NULL
-	NULL
am	NULL
@	NULL
-	NULL
Â»	NULL
@	NULL
rem	NULL
4	NULL
Gactls	NULL
33	NULL
-	NULL
``	NULL
Figure	NULL
3	NULL
The	NULL
unique	NULL
linker	NULL
region	NULL
of	NULL
Gads	NULL
contains	NULL
a	NULL
potential	NULL
caspase	NULL
cleavage	NULL
site	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
Gads	NULL
protein	NULL
indicating	NULL
the	NULL
location	NULL
of	NULL
the	NULL
potential	NULL
caspase	NULL
3	NULL
cleavage	NULL
site	NULL
(	NULL
DIND	NULL
Â»	NULL
;	NULL
$	NULL
)	NULL
and	NULL
the	NULL
region	NULL
of	NULL
Gads	NULL
recognized	NULL
by	NULL
the	NULL
anti-Gads	NULL
anti-sera	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
the	NULL
caspase	NULL
inhibitors	NULL
DEVD	NULL
(	NULL
caspase	NULL
3	NULL
)	NULL
,	NULL
VAD	NULL
(	NULL
caspase	NULL
8	NULL
)	NULL
or	NULL
YVAD	NULL
(	NULL
ICE	NULL
)	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
FasL	NULL
.	NULL

Gads	NULL
and	NULL
its	NULL
cleavage	NULL
product	NULL
were	NULL
detected	NULL
by	NULL
immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
with	NULL
anti-Gads	NULL
anti-sera	NULL
Oncogene	NULL
WT	NULL
3	NULL
7	NULL
=	NULL
D235A	NULL
Caspase	NULL
:	NULL
-	NULL
3	NULL
7	NULL
Gads-FL	NULL
Â¥	NULL
Â®	NULL
Â»	NULL
--	NULL
mo	NULL
ame	NULL
ome	NULL
Gadsci-N	NULL
DP	NULL
Â«	NULL
lll	NULL
:	NULL
Â»	NULL
Â»	NULL
...	NULL
Gadscl-C	NULL
Â®	NULL
FasL	NULL
:	NULL
0	NULL
-	NULL
2hrs	NULL
D	NULL
(	NULL
235	NULL
)	NULL
A	NULL
D	NULL
(	NULL
235	NULL
)	NULL
A	NULL
Tin	NULL
:	NULL
â¬	NULL
MW	NULL
55	NULL
38	NULL
__	NULL
Wits	NULL
Â«	NULL
o	NULL
Â«	NULL
Â»	NULL
C	NULL
Gacls	NULL
33	NULL
-	NULL
.	NULL

e	NULL
O*	NULL
Figure	NULL
4	NULL
Mutation	NULL
of	NULL
aspartate	NULL
residue	NULL
235	NULL
in	NULL
the	NULL
Gads	NULL
linker	NULL
region	NULL
inhibits	NULL
cleavage	NULL
by	NULL
caspase	NULL
3	NULL
.	NULL

(	NULL
a	NULL
)	NULL
*S-methionine	NULL
labeled	NULL
wild	NULL
type	NULL
Gads	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
a	NULL
mutant	NULL
form	NULL
of	NULL
Gads	NULL
in	NULL
which	NULL
aspartate	NULL
residue	NULL
235	NULL
was	NULL
changed	NULL
to	NULL
alanine	NULL
(	NULL
D235A	NULL
)	NULL
was	NULL
produced	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
and	NULL
incubated	NULL
with	NULL
recombinant	NULL
caspase	NULL
3	NULL
or	NULL
caspase	NULL
7	NULL
.	NULL

Cleavage	NULL
reactions	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
*S-methionine	NULL
labeled	NULL
Gads	NULL
products	NULL
were	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

(	NULL
b	NULL
)	NULL
To	NULL
confirm	NULL
that	NULL
D235	NULL
is	NULL
also	NULL
the	NULL
caspase	NULL
cleavage	NULL
site	NULL
in	NULL
vivo	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
Flag	NULL
epitope	NULL
tagged	NULL
wild	NULL
type	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
mutant	NULL
Gads	NULL
(	NULL
D235A	NULL
)	NULL
expression	NULL
plasmids	NULL
.	NULL

Following	NULL
FasL	NULL
treatment	NULL
Gads	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
using	NULL
anti-FLAG	NULL
,	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
membranes	NULL
were	NULL
blotted	NULL
with	NULL
anti-Gads	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
over	NULL
expression	NULL
of	NULL
Gads	NULL
alone	NULL
has	NULL
no	NULL
observable	NULL
effect	NULL
on	NULL
a	NULL
NFAT	NULL
driven	NULL
reporter	NULL
,	NULL
while	NULL
co-expression	NULL
of	NULL
Gads	NULL
with	NULL
SLP-76	NULL
results	NULL
in	NULL
synergistic	NULL
activation	NULL
of	NULL
NFAT	NULL
(	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Gads	NULL
cleavage	NULL
products	NULL
was	NULL
also	NULL
able	NULL
to	NULL
inhibit	NULL
the	NULL
synergistic	NULL
activation	NULL
of	NULL
NFAT	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
transient	NULL
SLP-76	NULL
and	NULL
wild	NULL
type	NULL
Gads	NULL
(	NULL
Figure	NULL
6a	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
when	NULL
the	NULL
cleavage	NULL
products	NULL
are	NULL
transiently	NULL
over	NULL
expressed	NULL
together	NULL
,	NULL
a	NULL
dosage	NULL
dependent	NULL
inhibition	NULL
of	NULL
SLP-76	NULL
enhanced	NULL
NFAT	NULL
activation	NULL
was	NULL
observed	NULL
(	NULL
Figure	NULL
6b	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
Gads	NULL
cleavage	NULL
products	NULL
function	NULL
as	NULL
dominant	NULL
inhibitors	NULL
of	NULL
SLP-76	NULL
dependent	NULL
signalling	NULL
Caspase-dependent	NULL
cleavage	NULL
of	NULL
Gads	NULL
DM	NULL
Berry	NULL
et	NULL
al	NULL
Tin	NULL
:	NULL
wT	NULL
CL-N	NULL
CcL-c	NULL
Â«	NULL
eCD3	NULL
:	NULL
-	NULL
+-	NULL
4+	NULL
-	NULL
+	NULL
mw	NULL
55	NULL
-	NULL
C	NULL
38	NULL
-	NULL
Â®	NULL
H	NULL
%	NULL
(	NULL
e	NULL
Â«	NULL
<	NULL
a	NULL
LAT	NULL
90	NULL
T0	NULL
-	NULL
Â«	NULL
mmm	NULL
anus	NULL
came	NULL
woe	NULL
Â«	NULL
Af	NULL
55	NULL
-	NULL
M	NULL
wee	NULL
a	NULL
SLP-76	NULL
118	NULL
90	NULL
TQ	NULL
--	NULL
was-	NULL
guam	NULL
--	NULL
Gl	NULL
55ââ-ââ_â_	NULL
36	NULL
-	NULL
t	NULL
HAH	NULL
a	NULL
Â«	NULL
<	NULL
&	NULL
p-Â¥	NULL
Figure	NULL
5	NULL
Gads	NULL
caspase	NULL
cleavage	NULL
products	NULL
retain	NULL
binding	NULL
speci-ficity	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
Flag-tagged	NULL
constructs	NULL
corresponding	NULL
to	NULL
the	NULL
N-terminal	NULL
(	NULL
CL-N	NULL
)	NULL
or	NULL
C-terminal	NULL
(	NULL
CL-C	NULL
)	NULL
cleavage	NULL
products	NULL
of	NULL
Gads	NULL
,	NULL
or	NULL
Flag-tagged	NULL
full-length	NULL
Gads	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
min	NULL
with	NULL
anti-CD3	NULL
.	NULL

Anti-Flag	NULL
immunoprecipitations	NULL
were	NULL
performed	NULL
on	NULL
clarified	NULL
lysates	NULL
to	NULL
identify	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
cleavage	NULL
products	NULL
.	NULL

Western	NULL
membranes	NULL
were	NULL
blotted	NULL
with	NULL
anti-LAT	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
,	NULL
anti-SLP-76	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
or	NULL
anti-phosphotyrosine	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
Gads	NULL
cleavage	NULL
products	NULL
retain	NULL
binding	NULL
specificity	NULL
for	NULL
LAT	NULL
and	NULL
SLP-76	NULL
.	NULL

The	NULL
anti-phosphotyrosine	NULL
blot	NULL
did	NULL
not	NULL
reveal	NULL
any	NULL
new	NULL
proteins	NULL
co-precipitating	NULL
with	NULL
the	NULL
cleavage	NULL
products	NULL
when	NULL
compared	NULL
to	NULL
full	NULL
length	NULL
Gads	NULL
.	NULL

Arrows	NULL
indicate	NULL
LAT	NULL
(	NULL
top	NULL
)	NULL
,	NULL
SLP-76	NULL
(	NULL
middle	NULL
)	NULL
,	NULL
or	NULL
phospho-SLP-76	NULL
or	NULL
phospho-LAT	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
and	NULL
suggests	NULL
that	NULL
,	NULL
in	NULL
vivo	NULL
,	NULL
cleavage	NULL
of	NULL
Gads	NULL
molecules	NULL
could	NULL
suppress	NULL
signalling	NULL
from	NULL
the	NULL
TCR	NULL
.	NULL

Discussion	NULL
Gads	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
SH2	NULL
and	NULL
SH3	NULL
domain-containing	NULL
adaptors	NULL
which	NULL
function	NULL
in	NULL
tyrosine	NULL
kinase	NULL
mediated	NULL
signalling	NULL
cascades	NULL
.	NULL

Gads	NULL
is	NULL
distinguished	NULL
from	NULL
the	NULL
other	NULL
two	NULL
members	NULL
of	NULL
this	NULL
family	NULL
,	NULL
Grb2	NULL
and	NULL
GRAP	NULL
,	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
unique	NULL
region	NULL
between	NULL
the	NULL
central	NULL
SH2	NULL
domain	NULL
and	NULL
the	NULL
carboxy	NULL
terminal	NULL
SH3	NULL
domain	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
one	NULL
consequence	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
unique	NULL
region	NULL
is	NULL
to	NULL
confer	NULL
sensitivity	NULL
to	NULL
caspase	NULL
cleavage	NULL
following	NULL
the	NULL
1207	NULL
Oncogene	NULL
Caspase-dependent	NULL
cleavage	NULL
of	NULL
Gads	NULL
DM	NULL
Berry	NULL
et	NULL
al	NULL
1208	NULL
C	NULL
Unstimulated	NULL
mCD3	NULL
m	NULL
CD3/PMA	NULL
a	NULL
Â©	NULL
no	NULL
w	NULL
w	NULL
in	NULL
0	NULL
in	NULL
Activity	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
a	NULL
38	NULL
SLP-76	NULL
SLP-76	NULL
+	NULL
CL-C	NULL
SLP-76	NULL
+	NULL
CL-N	NULL
SLP-76	NULL
+Gads	NULL
SLP-76	NULL
+	NULL
Gads	NULL
+	NULL
CL-N	NULL
Vector	NULL
SLP-76	NULL
+	NULL
Gads	NULL
+	NULL
CL-C	NULL
U	NULL
Unstimulated	NULL
Â©CD3	NULL
m	NULL
CD3/PMA	NULL
w	NULL
w	NULL
a	NULL
C	NULL
G	NULL
o	NULL
a	NULL
il	NULL
ba	NULL
a	NULL
Activity	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
SLP-76	NULL
SLP-76	NULL
+5ug	NULL
CLC	NULL
CL-N	NULL
SLP-76	NULL
+10ug	NULL
CLC	NULL
CL-N	NULL
SLP-76	NULL
+20ug	NULL
CL-C	NULL
CL-N	NULL
SLP.76	NULL
+40ug	NULL
CLC	NULL
CL-N	NULL
Vector	NULL
Figure	NULL
6	NULL
Gads	NULL
caspase	NULL
cleavage	NULL
products	NULL
inhibit	NULL
activation	NULL
of	NULL
NFAT	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Gads	NULL
cleavage	NULL
products	NULL
inhibit	NULL
the	NULL
enhanced	NULL
NFAT	NULL
activity	NULL
induced	NULL
by	NULL
SLP-76	NULL
and	NULL
Gads	NULL
expression	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
luciferase	NULL
cDNA	NULL
driven	NULL
by	NULL
the	NULL
NFAT-binding	NULL
site	NULL
from	NULL
the	NULL
IL2	NULL
promoter	NULL
and	NULL
either	NULL
empty	NULL
pEF-FLAG	NULL
vector	NULL
or	NULL
FLAG-tagged	NULL
SLP-76	NULL
,	NULL
wild-type	NULL
Gads	NULL
,	NULL
and/or	NULL
Gads	NULL
cleavage	NULL
constructs	NULL
(	NULL
CL-N	NULL
or	NULL
CL-C	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
anti-CD3	NULL
,	NULL
anti-CD3	NULL
+	NULL
PMA	NULL
or	NULL
ionomycin	NULL
+	NULL
PMA	NULL
(	NULL
maximum	NULL
stimulation	NULL
)	NULL
for	NULL
16	NULL
h	NULL
,	NULL
lysed	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
luminometer	NULL
.	NULL

The	NULL
results	NULL
(	NULL
mean	NULL
of	NULL
duplicates	NULL
)	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
arbitrary	NULL
luciferase	NULL
units	NULL
induced	NULL
by	NULL
ionomycin	NULL
plus	NULL
PMA	NULL
treatment	NULL
(	NULL
percent	NULL
of	NULL
maximum	NULL
)	NULL
.	NULL

No	NULL
difference	NULL
in	NULL
the	NULL
maximum	NULL
luciferase	NULL
units	NULL
induced	NULL
by	NULL
ionomycin	NULL
and	NULL
PMA	NULL
was	NULL
observed	NULL
between	NULL
transfectants	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Gads	NULL
cleavage	NULL
products	NULL
,	NULL
when	NULL
combined	NULL
,	NULL
inhibit	NULL
the	NULL
enhanced	NULL
NFAT	NULL
activation	NULL
induced	NULL
by	NULL
SLP-76	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
pEF-FLAG-SLP-76	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
Gads	NULL
CL-N	NULL
and	NULL
CL-C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
anti-CD3	NULL
,	NULL
anti-CD3+PMA	NULL
or	NULL
ionomycin+	NULL
PMA	NULL
(	NULL
maximum	NULL
stimulation	NULL
)	NULL
for	NULL
16	NULL
h	NULL
,	NULL
lysed	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
luminometer	NULL
.	NULL

The	NULL
results	NULL
(	NULL
mean	NULL
of	NULL
duplicates	NULL
)	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
arbitrary	NULL
luciferase	NULL
units	NULL
induced	NULL
by	NULL
ionomycin	NULL
plus	NULL
PMA	NULL
treatment	NULL
(	NULL
per	NULL
cent	NULL
of	NULL
maximum	NULL
)	NULL
initiation	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Cleavage	NULL
of	NULL
Gads	NULL
at	NULL
this	NULL
site	NULL
results	NULL
in	NULL
the	NULL
separation	NULL
of	NULL
the	NULL
Oncogene	NULL
carboxy	NULL
terminal	NULL
SH3	NULL
domain	NULL
from	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
Gads	NULL
molecule	NULL
,	NULL
effectively	NULL
uncoupling	NULL
Gads	NULL
SH3	NULL
binding	NULL
proteins	NULL
such	NULL
as	NULL
SLP-76	NULL
from	NULL
the	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
which	NULL
bind	NULL
the	NULL
Gads	NULL
SH2	NULL
domain	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Gads	NULL
cleavage	NULL
products	NULL
inhibits	NULL
signalling	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
.	NULL

In	NULL
the	NULL
periphery	NULL
,	NULL
reactive	NULL
T	NULL
cells	NULL
are	NULL
eliminated	NULL
by	NULL
activation	NULL
induced	NULL
cell	NULL
death	NULL
(	NULL
AICD	NULL
)	NULL
,	NULL
a	NULL
process	NULL
mediated	NULL
by	NULL
Fas	NULL
and	NULL
FasL	NULL
(	NULL
CD95/CD95L	NULL
)	NULL
during	NULL
the	NULL
down	NULL
regulation	NULL
of	NULL
an	NULL
immune	NULL
response	NULL
(	NULL
Brunner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Ju	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Russell	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Gads	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
linking	NULL
the	NULL
membrane	NULL
protein	NULL
LAT	NULL
,	NULL
with	NULL
SLP-76	NULL
(	NULL
Liu	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

The	NULL
assembly	NULL
of	NULL
a	NULL
SLP-76-Gads-LAT	NULL
complex	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
transduction	NULL
of	NULL
downstream	NULL
signals	NULL
such	NULL
as	NULL
calcium	NULL
mobilization	NULL
,	NULL
JNK	NULL
kinase	NULL
activation	NULL
and	NULL
NFAT	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Ishiai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Cleavage	NULL
of	NULL
Gads	NULL
,	NULL
would	NULL
result	NULL
in	NULL
both	NULL
the	NULL
loss	NULL
of	NULL
its	NULL
adaptor	NULL
function	NULL
as	NULL
well	NULL
as	NULL
the	NULL
production	NULL
of	NULL
cleavage	NULL
products	NULL
which	NULL
can	NULL
act	NULL
in	NULL
a	NULL
dominant	NULL
inhibitory	NULL
manner	NULL
.	NULL

Therefore	NULL
,	NULL
Gads	NULL
cleavage	NULL
would	NULL
effectively	NULL
result	NULL
in	NULL
the	NULL
uncoupling	NULL
of	NULL
signalling	NULL
pathways	NULL
downstream	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
during	NULL
apoptosis	NULL
and	NULL
cessation	NULL
of	NULL
proliferation	NULL
,	NULL
survival	NULL
and	NULL
activation	NULL
signals	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
Gads	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
Gads	NULL
associated-molecules	NULL
SLP-76	NULL
and	NULL
LAT	NULL
as	NULL
well	NULL
as	NULL
SLP-76	NULL
associated	NULL
SLAP-130/Fyb	NULL
are	NULL
cleaved	NULL
following	NULL
FasL	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
cells	NULL
.	NULL

SLP-76	NULL
,	NULL
LAT	NULL
and	NULL
SLAP-130/Fyb	NULL
all	NULL
contain	NULL
potential	NULL
caspase	NULL
3	NULL
sites	NULL
which	NULL
if	NULL
cleaved	NULL
would	NULL
yield	NULL
proteolytic	NULL
products	NULL
with	NULL
molecular	NULL
weights	NULL
consistent	NULL
with	NULL
the	NULL
electrophoretic	NULL
mobilities	NULL
of	NULL
those	NULL
observed	NULL
in	NULL
this	NULL
study	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
SLP-76	NULL
contains	NULL
four	NULL
putative	NULL
caspase	NULL
3	NULL
cleavage	NULL
sites	NULL
including	NULL
the	NULL
sequence	NULL
DEDD	NULL
(	NULL
amino	NULL
acids	NULL
320-323	NULL
)	NULL
.	NULL

Cleavage	NULL
at	NULL
this	NULL
site	NULL
would	NULL
yield	NULL
a	NULL
30	NULL
kDa	NULL
product	NULL
and	NULL
a	NULL
46	NULL
kDa	NULL
product	NULL
containing	NULL
the	NULL
anti-SLP-76	NULL
antibody	NULL
immunoreactive	NULL
region	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
putative	NULL
proteolytic	NULL
product	NULL
detected	NULL
in	NULL
Figure	NULL
1b	NULL
.	NULL

Whether	NULL
the	NULL
physical	NULL
association	NULL
of	NULL
these	NULL
molecules	NULL
in	NULL
this	NULL
complex	NULL
influences	NULL
their	NULL
susceptibility	NULL
to	NULL
cleavage	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Other	NULL
components	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
signalling	NULL
cascade	NULL
such	NULL
as	NULL
Vav	NULL
and	NULL
HPK1	NULL
have	NULL
also	NULL
been	NULL
identified	NULL
as	NULL
caspase	NULL
3	NULL
substrates	NULL
in	NULL
lymphocytes	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Hofmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Cleavage	NULL
of	NULL
these	NULL
signalling	NULL
enzymes	NULL
leads	NULL
to	NULL
alterations	NULL
in	NULL
their	NULL
catalytic	NULL
activity	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
HPK1	NULL
,	NULL
separation	NULL
of	NULL
the	NULL
C-terminal	NULL
regulatory	NULL
domain	NULL
from	NULL
the	NULL
N-terminal	NULL
kinase	NULL
domain	NULL
leads	NULL
to	NULL
enhanced	NULL
kinase	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
cleaved	NULL
peptides	NULL
have	NULL
a	NULL
reduced	NULL
capacity	NULL
to	NULL
associate	NULL
to	NULL
HPK1	NULL
binding	NULL
partners	NULL
Grb2	NULL
and	NULL
Crk	NULL
(	NULL
Chen	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

The	NULL
caspase-dependent	NULL
cleavage	NULL
of	NULL
Vavl	NULL
does	NULL
not	NULL
affect	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
JNK	NULL
,	NULL
a	NULL
kinase	NULL
which	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
a	NULL
positive	NULL
regulator	NULL
in	NULL
apoptosis	NULL
,	NULL
but	NULL
the	NULL
cleaved	NULL
form	NULL
of	NULL
Vavl	NULL
completely	NULL
fails	NULL
to	NULL
induce	NULL
IL-2	NULL
transcription	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
cleavage	NULL
of	NULL
Vavl	NULL
may	NULL
inhibit	NULL
signalling	NULL
from	NULL
the	NULL
TCR	NULL
(	NULL
Hofmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Gads	NULL
is	NULL
a	NULL
unique	NULL
example	NULL
of	NULL
an	NULL
adaptor	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
caspase	NULL
cleavage	NULL
.	NULL

The	NULL
functional	NULL
consequence	NULL
of	NULL
caspase	NULL
cleavage	NULL
of	NULL
Gads	NULL
is	NULL
likely	NULL
the	NULL
uncoupling	NULL
of	NULL
specific	NULL
signalling	NULL
pathways	NULL
proximal	NULL
to	NULL
the	NULL
TCR	NULL
,	NULL
rather	NULL
than	NULL
deregulation	NULL
of	NULL
a	NULL
signalling	NULL
enzyme	NULL
or	NULL
disassembly	NULL
of	NULL
a	NULL
structural	NULL
complex	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
inducing	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
there	NULL
is	NULL
some	NULL
evidence	NULL
that	NULL
Fas	NULL
mediated	NULL
signalling	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
proliferation	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
FADD	NULL
adaptor	NULL
protein	NULL
through	NULL
either	NULL
gene	NULL
targeting	NULL
or	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
FADD	NULL
has	NULL
revealed	NULL
some	NULL
surprising	NULL
effects	NULL
on	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Though	NULL
FADD	NULL
knock-out	NULL
mice	NULL
were	NULL
embryonic	NULL
lethal	NULL
(	NULL
Â¥eh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998a	NULL
)	NULL
,	NULL
thymic	NULL
reconstitution	NULL
of	NULL
RAG-1	NULL
deficient	NULL
chimeric	NULL
mice	NULL
revealed	NULL
the	NULL
expected	NULL
defects	NULL
in	NULL
Fas-induced	NULL
T	NULL
cell	NULL
apoptosis	NULL
,	NULL
but	NULL
surprisingly	NULL
cells	NULL
were	NULL
also	NULL
resistant	NULL
to	NULL
activation	NULL
induced	NULL
proliferation	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998a	NULL
)	NULL
.	NULL

Additional	NULL
evidence	NULL
for	NULL
FADDs	NULL
proliferative	NULL
role	NULL
is	NULL
provided	NULL
by	NULL
studies	NULL
examining	NULL
mice	NULL
which	NULL
express	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
FADD	NULL
;	NULL
T	NULL
cells	NULL
from	NULL
these	NULL
mice	NULL
also	NULL
have	NULL
defects	NULL
in	NULL
proliferation	NULL
and	NULL
calcium	NULL
mobilization	NULL
(	NULL
Hueber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Zornig	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
paradoxical	NULL
effect	NULL
of	NULL
cell	NULL
death	NULL
pathways	NULL
on	NULL
T	NULL
cell	NULL
proliferation	NULL
may	NULL
be	NULL
mediated	NULL
via	NULL
the	NULL
cleavage	NULL
of	NULL
signalling	NULL
molecules	NULL
downstream	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
which	NULL
could	NULL
modulate	NULL
the	NULL
spectrum	NULL
of	NULL
pathways	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
a	NULL
given	NULL
signal	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Antisera	NULL
and	NULL
antibodies	NULL
Production	NULL
of	NULL
affinity-purified	NULL
polyclonal	NULL
Gads	NULL
antibody	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Liu	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
monoclonal	NULL
anti-phosphotyrosine	NULL
antibody	NULL
4G10	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
was	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1	NULL
:	NULL
1000	NULL
.	NULL

Anti-FLAG	NULL
M2	NULL
antibodies	NULL
(	NULL
Sigma	NULL
)	NULL
were	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:1000	NULL
for	NULL
Western	NULL
blotting	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
were	NULL
used	NULL
in	NULL
immunoprecipitations	NULL
.	NULL

Polyclonal	NULL
anti-SOS1	NULL
and	NULL
anti-SOS2	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
and	NULL
both	NULL
were	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1	NULL
:	NULL
500	NULL
for	NULL
Western	NULL
blotting	NULL
.	NULL

Affinity-purified	NULL
polyclonal	NULL
anti-LAT	NULL
antibody	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
,	NULL
anti-phospholipase	NULL
Cy	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
and	NULL
anti-Grb2	NULL
antibody	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
)	NULL
were	NULL
used	NULL
at	NULL
a	NULL
dilutions	NULL
of	NULL
1:250	NULL
,	NULL
1:1000	NULL
and	NULL
1:500	NULL
,	NULL
respectively	NULL
for	NULL
Western	NULL
blotting	NULL
.	NULL

Anti-SLP-76	NULL
and	NULL
anti-SLAP-130	NULL
polyclonal	NULL
antisera	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
G	NULL
Koretzky	NULL
)	NULL
were	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1	NULL
:	NULL
500	NULL
for	NULL
Western	NULL
blotting	NULL
with	NULL
a	NULL
donkey	NULL
anti-sheep-HRP	NULL
secondary	NULL
(	NULL
1:25000	NULL
)	NULL
.	NULL

All	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
were	NULL
followed	NULL
with	NULL
a	NULL
goat	NULL
anti-rabbit-HRP	NULL
from	NULL
Amersham	NULL
(	NULL
1	NULL
:	NULL
5000	NULL
)	NULL
and	NULL
all	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
detected	NULL
with	NULL
sheep	NULL
anti-mouse	NULL
HRP	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Plasmids	NULL
and	NULL
mutagenesis	NULL
Wild	NULL
type	NULL
full-length	NULL
Gads	NULL
was	NULL
subcloned	NULL
,	NULL
in	NULL
frame	NULL
with	NULL
an	NULL
amino	NULL
terminal-FLAG	NULL
epitope	NULL
tag	NULL
,	NULL
into	NULL
a	NULL
modified	NULL
pEFBOS	NULL
vector	NULL
containing	NULL
a	NULL
EF-1	NULL
promoter	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Liu	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Gads	NULL
(	NULL
D235A	NULL
)	NULL
was	NULL
made	NULL
by	NULL
substituting	NULL
aspartic	NULL
acid	NULL
residue	NULL
235	NULL
with	NULL
an	NULL
alanine	NULL
using	NULL
PCR-based	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

Gads	NULL
(	NULL
D235A	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
pcDNA3.1	NULL
with	NULL
an	NULL
amino-terminal	NULL
HA-epitope	NULL
tag	NULL
and	NULL
pEF	NULL
Caspase-dependent	NULL
cleavage	NULL
of	NULL
Gads	NULL
DM	NULL
Berry	NULL
et	NULL
al	NULL
vector	NULL
with	NULL
an	NULL
amino-terminal	NULL
FLAG	NULL
epitope	NULL
tag	NULL
.	NULL

The	NULL
constructs	NULL
corresponding	NULL
to	NULL
the	NULL
putative	NULL
Gads	NULL
caspase	NULL
cleavage	NULL
products	NULL
(	NULL
Gads-N	NULL
and	NULL
Gads-C	NULL
)	NULL
were	NULL
amplified	NULL
from	NULL
Gads	NULL
full-length	NULL
cDNA	NULL
and	NULL
cloned	NULL
into	NULL
pEF	NULL
vector	NULL
with	NULL
an	NULL
amino-terminal	NULL
FLAG	NULL
tag	NULL
.	NULL

Cell	NULL
culture	NULL
Jurkat	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
37Â°C	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
foetal	NULL
bovine	NULL
serum	NULL
(	NULL
Wisent	NULL
)	NULL
,	NULL
5	NULL
U/ml	NULL
penicillin	NULL
C	NULL
and	NULL
5	NULL
mg/m	NULL
!	NULL

streptomycin	NULL
sulphate	NULL
.	NULL

Primary	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
and	NULL
cultured	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Liu	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
induced	NULL
by	NULL
culturing	NULL
cells	NULL
in	NULL
media	NULL
with	NULL
15	NULL
ng/ml	NULL
of	NULL
Fas	NULL
ligand	NULL
and	NULL
1.5	NULL
ug	NULL
ml	NULL
of	NULL
a	NULL
cross-linking	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
.	NULL

For	NULL
the	NULL
caspase	NULL
inhibitor	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
50	NULL
um	NULL
AcYVAD-CHO	NULL
,	NULL
z-VAD-FMK	NULL
,	NULL
or	NULL
z-DEVD-FMK	NULL
(	NULL
dissolved	NULL
in	NULL
DMSO	NULL
)	NULL
,	NULL
before	NULL
stimulation	NULL
with	NULL
Fas	NULL
ligand	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
experiment	NULL
,	NULL
apoptosis	NULL
was	NULL
induced	NULL
by	NULL
culturing	NULL
Jurkat	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
uM	NULL
staurosporine	NULL
for	NULL
3	NULL
h	NULL
or	NULL
40	NULL
um	NULL
etoposide	NULL
for	NULL
24	NULL
h.	NULL
Transient	NULL
transfection	NULL
and	NULL
luciferase	NULL
assays	NULL
For	NULL
transient	NULL
transfections	NULL
2	NULL
x	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
40	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
plasmids	NULL
in	NULL
electropora-tion	NULL
buffer	NULL
(	NULL
120	NULL
mm	NULL
KCI	NULL
,	NULL
0.5	NULL
mm	NULL
CaC	NULL
)	NULL
;	NULL
,	NULL
10	NULL
mm	NULL
K	NULL
,	NULL
HPOy4	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
25	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
2	NULL
mm	NULL
EGTA	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
5	NULL
mm	NULL
MgC1	NULL
;	NULL
)	NULL
with	NULL
a	NULL
Gene	NULL
Pulser	NULL
(	NULL
BioRad	NULL
)	NULL
set	NULL
at	NULL
250	NULL
V	NULL
and	NULL
960	NULL
uF	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
,	NULL
harvested	NULL
and	NULL
processed	NULL
as	NULL
described	NULL
below	NULL
.	NULL

For	NULL
NFAT-luciferase	NULL
reporter	NULL
assays	NULL
,	NULL
2x	NULL
10	NULL
'	NULL
Jurkat	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
20	NULL
ug	NULL
NFAT	NULL
luciferase	NULL
reporter	NULL
construct	NULL
,	NULL
together	NULL
with	NULL
40	NULL
ug	NULL
of	NULL
empty	NULL
pEF	NULL
vector	NULL
or	NULL
40	NULL
ug	NULL
Gads	NULL
wt	NULL
,	NULL
SLP-76	NULL
,	NULL
Gads-N	NULL
or	NULL
Gads-C	NULL
in	NULL
combinations	NULL
described	NULL
for	NULL
each	NULL
individual	NULL
experiment	NULL
.	NULL

To	NULL
control	NULL
for	NULL
differences	NULL
in	NULL
transfectional	NULL
efficiency	NULL
,	NULL
empty	NULL
pEF	NULL
vector	NULL
was	NULL
used	NULL
to	NULL
be	NULL
equalize	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
used	NULL
in	NULL
each	NULL
transfection	NULL
and	NULL
equivalent	NULL
expression	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
5x	NULL
10Â°	NULL
cells	NULL
were	NULL
stimulated	NULL
(	NULL
in	NULL
duplicate	NULL
)	NULL
as	NULL
indicated	NULL
for	NULL
16	NULL
h	NULL
at	NULL
37Â°C	NULL
and	NULL
lysed	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
quantified	NULL
with	NULL
a	NULL
luminometer	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Fang	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
relative	NULL
to	NULL
cells	NULL
treated	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
(	NULL
maximum	NULL
stimulation	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
For	NULL
CD3-stimulation	NULL
experiments	NULL
,	NULL
20	NULL
million	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
500	NULL
ul	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
,	NULL
prewarmed	NULL
at	NULL
37Â°C	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
were	NULL
then	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
human	NULL
anti-CD3	NULL
antibody	NULL
(	NULL
UCHT1-Pharmingen	NULL
)	NULL
for	NULL
2	NULL
min	NULL
at	NULL
37Â°C	NULL
.	NULL

Stimula-tions	NULL
were	NULL
halted	NULL
by	NULL
addition	NULL
of	NULL
ice	NULL
cold	NULL
phosphatase	NULL
inhibitor	NULL
buffer	NULL
(	NULL
PBS	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
mM	NULL
Na	NULL
,	NULL
P,0	NULL
;	NULL
,	NULL
100	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
;	NULL
VO4	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
lysed	NULL
in	NULL
PLC	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
HEPES	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1.5	NULL
mM	NULL
MgC1	NULL
;	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
mM	NULL
Na4	NULL
,	NULL
P	NULL
>	NULL
07	NULL
,	NULL
100	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
;	NULL
VO4	NULL
)	NULL
containing	NULL
protease	NULL
inhibitors	NULL
.	NULL

Lysates	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
14000	NULL
r.p.m	NULL
.	NULL

for	NULL
10	NULL
min	NULL
at	NULL
4Â°C	NULL
.	NULL

Clarified	NULL
lysates	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
90	NULL
min	NULL
with	NULL
protein	NULL
A-sepharose	NULL
or	NULL
protein	NULL
G-sepharose	NULL
(	NULL
Sigma	NULL
)	NULL
with	NULL
appropriate	NULL
antibody	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Beads	NULL
were	NULL
then	NULL
washed	NULL
five	NULL
times	NULL
with	NULL
1	NULL
ml	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
and	NULL
protein	NULL
complexes	NULL
were	NULL
released	NULL
by	NULL
boiling	NULL
sepharose	NULL
beads	NULL
in	NULL
SDS-Laemmli	NULL
sample	NULL
buffer	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Eluted	NULL
proteins	NULL
were	NULL
1209	NULL
Oncogene	NULL
Caspase-dependent	NULL
cleavage	NULL
of	NULL
Gads	NULL
DM	NULL
Berry	NULL
et	NULL
al	NULL
1210	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

All	NULL
membranes	NULL
were	NULL
blocked	NULL
with	NULL
Tris-buffered	NULL
saline	NULL
containing	NULL
1	NULL
%	NULL
Tween	NULL
(	NULL
TBST	NULL
)	NULL
and	NULL
5	NULL
%	NULL
milk	NULL
powder	NULL
,	NULL
or	NULL
in	NULL
the	NULL
case	NULL
of	NULL
phosphotyrosine	NULL
blotting	NULL
,	NULL
TBST	NULL
containing	NULL
1	NULL
%	NULL
BSA	NULL
.	NULL

Following	NULL
1	NULL
h	NULL
of	NULL
blocking	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
membranes	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
blocking	NULL
buffer	NULL
containing	NULL
primary	NULL
antibody	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Following	NULL
incubation	NULL
with	NULL
primary	NULL
antibody	NULL
,	NULL
membranes	NULL
were	NULL
washed	NULL
with	NULL
TBST	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
appropriate	NULL
secondary	NULL
antibodies	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
washed	NULL
thoroughly	NULL
and	NULL
antibodies	NULL
were	NULL
visualized	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
and	NULL
autoradiography	NULL
.	NULL

In	NULL
vitro	NULL
cleavage	NULL
assays	NULL
For	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
reactions	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
peDNA3.1	NULL
wild	NULL
type	NULL
or	NULL
D235A	NULL
Gads	NULL
was	NULL
incubated	NULL
with	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
and	NULL
reaction	NULL
components	NULL
,	NULL
including	NULL
$	NULL
*	NULL
Methionine	NULL
for	NULL
90	NULL
min	NULL
at	NULL
30Â°C	NULL
according	NULL
to	NULL
the	NULL
manufactuer	NULL
's	NULL
instructions	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Fifteen	NULL
ul	NULL
of	NULL
each	NULL
References	NULL
Asada	NULL
H	NULL
,	NULL
Ishii	NULL
N	NULL
,	NULL
Sasaki	NULL
Y	NULL
,	NULL
Endo	NULL
K	NULL
,	NULL
Kasai	NULL
H	NULL
,	NULL
Tanaka	NULL
N	NULL
,	NULL
Takeshita	NULL
T	NULL
,	NULL
Tsuchiya	NULL
S	NULL
,	NULL
Konno	NULL
T	NULL
and	NULL
Sugamura	NULL
K.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
189	NULL
,	NULL
1383-1390	NULL
.	NULL

Brunner	NULL
T	NULL
,	NULL
Mogil	NULL
RJ	NULL
,	NULL
LaFace	NULL
D	NULL
,	NULL
Yoo	NULL
NJ	NULL
,	NULL
Mahboubi	NULL
A	NULL
,	NULL
Echeverri	NULL
F	NULL
,	NULL
Martin	NULL
SJ	NULL
,	NULL
Force	NULL
WR	NULL
,	NULL
Lynch	NULL
DH	NULL
and	NULL
Ware	NULL
CF	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
373	NULL
,	NULL
441-444	NULL
.	NULL

Buday	NULL
L	NULL
,	NULL
Egan	NULL
SE	NULL
,	NULL
Rodriguez	NULL
Viciana	NULL
P	NULL
,	NULL
Cantrell	NULL
DA	NULL
and	NULL
Downward	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
,	NULL
9019-9023	NULL
.	NULL

Bustelo	NULL
XR	NULL
,	NULL
Ledbetter	NULL
JA	NULL
and	NULL
Barbacid	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
,	NULL
Nature	NULL
,	NULL
356	NULL
,	NULL
68-71	NULL
.	NULL

Chan	NULL
AC	NULL
,	NULL
Dalton	NULL
M	NULL
,	NULL
Johnson	NULL
R	NULL
,	NULL
Kong	NULL
GH	NULL
,	NULL
Wang	NULL
T	NULL
,	NULL
Thoma	NULL
R	NULL
and	NULL
Kurosaki	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

EMBO	NULL
.	NULL

J.	NULL
,	NULL
14	NULL
,	NULL
2499	NULL
2508	NULL
.	NULL

Chan	NULL
AC	NULL
and	NULL
Shaw	NULL
AS	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
394-401	NULL
.	NULL

Chen	NULL
Y-R	NULL
,	NULL
Meyer	NULL
CF	NULL
,	NULL
Ahmed	NULL
B	NULL
,	NULL
Yao	NULL
Z	NULL
and	NULL
Tan	NULL
T-H.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
18	NULL
,	NULL
7370-7377	NULL
.	NULL

Earnshaw	NULL
WC	NULL
,	NULL
Martins	NULL
LM	NULL
and	NULL
Kaufmann	NULL
SH	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
68	NULL
,	NULL
383-424	NULL
.	NULL

Fadeel	NULL
B	NULL
,	NULL
Orrenius	NULL
S	NULL
and	NULL
Zhivotovsky	NULL
B	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Leukemia	NULL
,	NULL
14	NULL
,	NULL
1514-1525	NULL
.	NULL

Fang	NULL
N	NULL
,	NULL
Motto	NULL
DG	NULL
,	NULL
Ross	NULL
SE	NULL
and	NULL
Koretzky	NULL
GA.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
157	NULL
,	NULL
3769-3773	NULL
.	NULL

Finco	NULL
TS	NULL
,	NULL
Kadlecek	NULL
T	NULL
,	NULL
Zhang	NULL
W	NULL
,	NULL
Samelson	NULL
LE	NULL
and	NULL
Weiss	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
9	NULL
,	NULL
617-626	NULL
.	NULL

Hofmann	NULL
TG	NULL
,	NULL
Hehner	NULL
SP	NULL
,	NULL
Droge	NULL
W	NULL
and	NULL
Schmitz	NULL
ML	NULL
(	NULL
2000	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
19	NULL
,	NULL
1153-1163	NULL
.	NULL

Hueber	NULL
AO	NULL
,	NULL
Zornig	NULL
M	NULL
,	NULL
Bernard	NULL
AM	NULL
,	NULL
Chautan	NULL
M	NULL
and	NULL
Evan	NULL
G.	NULL
(	NULL
2000	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
275	NULL
,	NULL
10453-10462	NULL
.	NULL

Ishiai	NULL
M	NULL
,	NULL
Kurosaki	NULL
M	NULL
,	NULL
Inabe	NULL
K	NULL
,	NULL
Chan	NULL
AC	NULL
,	NULL
Sugamura	NULL
K	NULL
and	NULL
Kurosaki	NULL
T.	NULL
(	NULL
2000	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
192	NULL
,	NULL
847-856	NULL
.	NULL

Jackman	NULL
JK	NULL
,	NULL
Motto	NULL
DG	NULL
,	NULL
Sun	NULL
QM	NULL
,	NULL
Tanemoto	NULL
M	NULL
,	NULL
Turck	NULL
CW	NULL
,	NULL
Pelz	NULL
GA	NULL
,	NULL
Koretzky	NULL
GA	NULL
and	NULL
Findell	NULL
PR	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

J.	NULL
Bio/	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
7029-7032	NULL
.	NULL

Ju	NULL
ST	NULL
,	NULL
Panka	NULL
DJ	NULL
,	NULL
Cui	NULL
H	NULL
,	NULL
Ettinger	NULL
R	NULL
,	NULL
el-Khatib	NULL
M	NULL
,	NULL
Sherr	NULL
DH	NULL
,	NULL
Stanger	NULL
BZ	NULL
and	NULL
Marshak-Rothstein	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
373	NULL
,	NULL
444-448	NULL
.	NULL

Law	NULL
CL	NULL
,	NULL
Ewings	NULL
MK	NULL
,	NULL
Chaudhary	NULL
PM	NULL
,	NULL
Solow	NULL
SA	NULL
,	NULL
Yun	NULL
TJ	NULL
,	NULL
Marshall	NULL
AJ	NULL
,	NULL
Hood	NULL
L	NULL
and	NULL
Clark	NULL
EA	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
189	NULL
,	NULL
1243-1253	NULL
.	NULL

Oncogene	NULL
reaction	NULL
was	NULL
then	NULL
immunoprecipitated	NULL
with	NULL
affinity-purified	NULL
anti-Gads	NULL
antibody	NULL
for	NULL
90	NULL
min	NULL
and	NULL
then	NULL
washed	NULL
3x	NULL
with	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
.	NULL

Immunoprecipitations	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
caspase	NULL
reaction	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
10	NULL
mm	NULL
DTT	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
CHAPS	NULL
)	NULL
with	NULL
or	NULL
without	NULL
150	NULL
ng	NULL
of	NULL
recombinant	NULL
caspase-3	NULL
or	NULL
caspase-7	NULL
(	NULL
Pharmingen	NULL
)	NULL
.	NULL

Protein	NULL
samples	NULL
were	NULL
then	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
Stan	NULL
Liu	NULL
for	NULL
lively	NULL
discussions	NULL
,	NULL
Dr	NULL
Gary	NULL
Koretzky	NULL
for	NULL
anti-SLP-76	NULL
and	NULL
anti-SLAP-130	NULL
anti-serum	NULL
and	NULL
Dr	NULL
Ian	NULL
Clarke	NULL
for	NULL
isolating	NULL
primary	NULL
lympho-cytes	NULL
.	NULL

This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
operating	NULL
grants	NULL
from	NULL
the	NULL
Cancer	NULL
Research	NULL
Society	NULL
and	NULL
from	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
to	NULL
CJ	NULL
McGlade	NULL
.	NULL

SJ	NULL
Benn	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
Natural	NULL
Science	NULL
and	NULL
Engineering	NULL
Research	NULL
Council	NULL
Fellowship	NULL
.	NULL

CJ	NULL
McGlade	NULL
is	NULL
a	NULL
Research	NULL
Scientist	NULL
of	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
of	NULL
Canada	NULL
supported	NULL
with	NULL
funds	NULL
from	NULL
the	NULL
Canadian	NULL
Cancer	NULL
Society	NULL
.	NULL

Liu	NULL
SK	NULL
,	NULL
Fang	NULL
N	NULL
,	NULL
Koretzky	NULL
GA	NULL
and	NULL
McGlade	NULL
CJ	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
67-75	NULL
.	NULL

Liu	NULL
SK	NULL
and	NULL
McGlade	NULL
CJ	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
17	NULL
,	NULL
3073-3082	NULL
.	NULL

Martin	NULL
DA	NULL
Siegel	NULL
RM	NULL
,	NULL
Zheng	NULL
L	NULL
and	NULL
Lenardo	NULL
MJ	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
273	NULL
,	NULL
4345-4349	NULL
.	NULL

Motto	NULL
DG	NULL
,	NULL
Ross	NULL
SE	NULL
,	NULL
Wu	NULL
J	NULL
,	NULL
Hendricks	NULL
Taylor	NULL
LR	NULL
and	NULL
Koretzky	NULL
GA.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
183	NULL
,	NULL
1937-1943	NULL
.	NULL

Muzio	NULL
M	NULL
,	NULL
Stockwell	NULL
BR	NULL
,	NULL
Stennicke	NULL
HR	NULL
,	NULL
Salvesen	NULL
GS	NULL
and	NULL
Dixit	NULL
VM	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
273	NULL
,	NULL
2926-2930	NULL
.	NULL

Nel	NULL
AE	NULL
,	NULL
Gupta	NULL
S	NULL
,	NULL
Lee	NULL
L	NULL
,	NULL
Ledbetter	NULL
JA	NULL
and	NULL
Kanner	NULL
SB	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
18428-18436	NULL
.	NULL

Nicholson	NULL
DW	NULL
,	NULL
Ali	NULL
A	NULL
,	NULL
Thornberry	NULL
NA	NULL
,	NULL
Vaillancourt	NULL
JP	NULL
,	NULL
Ding	NULL
CK	NULL
,	NULL
Gallant	NULL
M	NULL
,	NULL
Gareau	NULL
Y	NULL
,	NULL
Griffin	NULL
PR	NULL
,	NULL
Labelle	NULL
M	NULL
and	NULL
Lazebnik	NULL
YA	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
376	NULL
,	NULL
37-43	NULL
.	NULL

Russell	NULL
JH	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
382-388	NULL
.	NULL

Villa	NULL
P	NULL
,	NULL
Kaufmann	NULL
SH	NULL
and	NULL
Earnshaw	NULL
WC	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
22	NULL
,	NULL
388-393	NULL
.	NULL

Wange	NULL
RL	NULL
,	NULL
Malek	NULL
SN	NULL
,	NULL
Desiderio	NULL
S	NULL
and	NULL
Samelson	NULL
LE	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
,	NULL
19797-19801	NULL
.	NULL

Wange	NULL
RL	NULL
and	NULL
Samelson	NULL
LE	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
5	NULL
,	NULL
197-205	NULL
.	NULL

Weber	NULL
JR	NULL
,	NULL
Orstavik	NULL
S	NULL
,	NULL
Torgersen	NULL
KM	NULL
,	NULL
Danbolt	NULL
NC	NULL
,	NULL
Berg	NULL
SF	NULL
,	NULL
Ryan	NULL
JC	NULL
,	NULL
Tasken	NULL
K	NULL
,	NULL
Imboden	NULL
JB	NULL
and	NULL
Vaage	NULL
JT	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
187	NULL
,	NULL
1157-1161	NULL
.	NULL

Weiss	NULL
A	NULL
,	NULL
Koretzky	NULL
G	NULL
,	NULL
Schatzman	NULL
RC	NULL
and	NULL
Kadlecek	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
5484-5488	NULL
.	NULL

Yablonski	NULL
D	NULL
,	NULL
Kuhne	NULL
MR	NULL
,	NULL
Kadlecek	NULL
T	NULL
and	NULL
Weiss	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Science	NULL
.	NULL

,	NULL
281	NULL
,	NULL
413-416	NULL
.	NULL

Yang	NULL
X	NULL
,	NULL
Chang	NULL
HY	NULL
and	NULL
Baltimore	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

,	NULL
1	NULL
,	NULL
319-325	NULL
.	NULL

Yeh	NULL
WC	NULL
,	NULL
Pompa	NULL
JL	NULL
,	NULL
McCurrach	NULL
ME	NULL
,	NULL
Shu	NULL
HB	NULL
,	NULL
Elia	NULL
AJ	NULL
,	NULL
Shahinian	NULL
A	NULL
,	NULL
Ng	NULL
M	NULL
,	NULL
Wakeham	NULL
A	NULL
,	NULL
Khoo	NULL
W	NULL
,	NULL
Mitchell	NULL
K	NULL
,	NULL
El-Deiry	NULL
WS	NULL
,	NULL
Lowe	NULL
SW	NULL
,	NULL
Goeddel	NULL
DV	NULL
and	NULL
Mak	NULL
TW	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
279	NULL
,	NULL
1954-1958	NULL
.	NULL

Yuan	NULL
J	NULL
,	NULL
Shaham	NULL
S	NULL
,	NULL
Ledoux	NULL
S	NULL
,	NULL
Ellis	NULL
HM	NULL
and	NULL
Horvitz	NULL
HR	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
75	NULL
,	NULL
641-652	NULL
.	NULL

Zhang	NULL
J	NULL
,	NULL
Cado	NULL
D	NULL
,	NULL
Chen	NULL
A	NULL
,	NULL
Kabra	NULL
NH	NULL
and	NULL
Winoto	NULL
A	NULL
(	NULL
1998a	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
392	NULL
,	NULL
296-300	NULL
.	NULL

Zhang	NULL
W	NULL
,	NULL
Sloan-Lancaster	NULL
J	NULL
,	NULL
Kitchen	NULL
J	NULL
,	NULL
Tible	NULL
RP	NULL
and	NULL
Samelson	NULL
LE	NULL
.	NULL

(	NULL
1998b	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
92	NULL
,	NULL
83-92	NULL
.	NULL

Caspase-dependent	NULL
cleavage	NULL
of	NULL
Gads	NULL
m	NULL
DM	NULL
Berry	NULL
et	NULL
al	NULL
1211	NULL
Zhang	NULL
W	NULL
,	NULL
Sommers	NULL
CL	NULL
,	NULL
Burshtyn	NULL
DN	NULL
,	NULL
Stebbins	NULL
CC	NULL
,	NULL
Zhang	NULL
W	NULL
,	NULL
Trible	NULL
RP	NULL
,	NULL
Zhu	NULL
M	NULL
,	NULL
Liu	NULL
SK	NULL
,	NULL
McGlade	NULL
CJ	NULL
and	NULL
DeJarnette	NULL
JB	NULL
,	NULL
Trible	NULL
RP	NULL
,	NULL
Grinberg	NULL
A	NULL
,	NULL
Tsay	NULL
HC	NULL
,	NULL
Jacobs	NULL
Samelson	NULL
LE	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
275	NULL
,	NULL
23355-23361	NULL
.	NULL

HM	NULL
,	NULL
Kessler	NULL
CM	NULL
,	NULL
Long	NULL
EO	NULL
,	NULL
Love	NULL
PE	NULL
and	NULL
Samelson	NULL
LE	NULL
.	NULL

Zornig	NULL
M	NULL
,	NULL
Hueber	NULL
AO	NULL
and	NULL
Evan	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
10	NULL
,	NULL
323-332	NULL
.	NULL

467-470	NULL
.	NULL

Oncogene	NULL

